New generation of prosthetic gets closer to the real limb

February 10, 2011

A UT Arlington bioengineer has built a neural interface that he thinks will lead to a better prosthetic arm that will allow more movement and eventually sensation for military veterans who desperately need them.

Mario Romero-Ortega and his team at The University of Texas at Arlington have obtained a new $2.2 million grant from , the research and development office for the U.S. Department of Defense, to further the development of technology that will allow amputees to naturally control and feel bionic limbs.

The grant is part of a program known as reliable neural interfacing (RENET), led by Dr. Jack Judy, program director of DARPA’s Microsystems Technology Office in Arlington, Va.

Robotic prosthetics has advanced from the simple hooks used starting in the 1850s to multi-finger, electronically controlled hands with 22 degrees of freedom. The modern devices closely resemble a human hand.

But neural interfaces are required to give amputees the most natural control and sensory perception. The process involves connecting the robotic prosthetic to the nervous system of the user. Current essential technology is unreliable.

Human arms are controlled through thousands of nerve “channels” that allow the limb, hand and fingers to operate independently precisely. The channels allow for motion and sensory control.

By contrast, the most advanced neural interface for prosthetic arms uses six to eight channels and allows only for simple movement without sensation. Neural interfaces directly implanted in the brain can provide hundreds more channels, but require invasive surgery.

“What makes our research different is that we’re putting the neural interface in the limb itself,” said Romero-Ortega, speaking of the tiny interfaces that allow the arm to interpret what the brain is telling it to do, and for the brain to interpret what the arm is doing.

About 90 percent of existing research in robotics and prosthetics focuses on the head, in what is called Brain-Machine Interfaces, Romero-Ortega said. Yet there is still no long-term, neural-electronic interface, he said.

“Our research moves away from the head and into the appendage itself, looking for neural reliability and stability. It integrates the nerve into electrodes through nerve regeneration,” he added.

Romero-Ortega’s team wants to open up more of those channels to the arm through electrical and molecular engineering. The aim is to find clear signals, and results that lead to clinically viable engineered systems with sufficient reliability and stability for 50 to 70 years of usage.

Romero-Ortega said initial testing shows the potential to open up hundreds of nerve channels to a prosthetic. These open channels will enable the body to control the prosthetic as if it were real, giving new functionality to amputees, such as military veterans who have survived catastrophic injuries to their limbs.

Romero-Ortega said team members bring unique strengths to the research lab. His expertise is in neuroscience, nerve regeneration, molecular biology and regenerative neural interface. Young-tae Kim, a UT Arlington bioengineering assistant professor, works with markers of inflammation, bioengineering, neurointerfaces and histology. Yan Li, a UT Arlington assistant professor of mathematics, specializes in biostatistics and biometrics.

The project also includes Harvey Wiggins and Edward Keefer, president/founder and research scientist of Dallas-based Plexon, who bring their expertise in neurophysiology, multi-electrode electrophysiology and biochemistry to the research effort.

Related Stories

Recommended for you

Engineered protein treatment found to reduce obesity in mice, rats and primates

October 19, 2017
(Medical Xpress)—A team of researchers with pharmaceutical company Amgen Inc. report that an engineered version of a protein naturally found in the body caused test mice, rats and cynomolgus monkeys to lose weight. In their ...

New procedure enables cultivation of human brain sections in the petri dish

October 19, 2017
Researchers at the University of Tübingen have become the first to keep human brain tissue alive outside the body for several weeks. The researchers, headed by Dr. Niklas Schwarz, Dr. Henner Koch and Dr. Thomas Wuttke at ...

Cancer drug found to offer promising results in treating sepsis in test mice

October 19, 2017
(Medical Xpress)—A combined team of researchers from China and the U.S. has found that a drug commonly used to treat lung cancer in humans offers a degree of protection against sepsis in test mice. In their paper published ...

Study reveals key molecular link in major cell growth pathway

October 19, 2017
A team of scientists led by Whitehead Institute has uncovered a surprising molecular link that connects how cells regulate growth with how they sense and make available the nutrients required for growth. Their work, which ...

Tracing cell death pathway points to drug targets for brain damage, kidney injury, asthma

October 19, 2017
University of Pittsburgh scientists are unlocking the complexities of a recently discovered cell death process that plays a key role in health and disease, and new findings link their discovery to asthma, kidney injury and ...

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.